Agno Pharma

Agno Pharma is a global small-molecule CDMO company that provides key intermediates, active pharmaceutical ingredients (APIs), high-potency APIs, sterile APIs, and sterile drug product formulations to large and mid-sized pharmaceutical, biotech, and CDMO clients. Agno possesses process development capabilities and FDA-inspected, GMP-compliant manufacturing facilities with the capacity for sterile suspension injections. Additionally, Agno has established a pharmaceutical formulation R&D lab for complex injectables. Agno has invested in its personnel and facilities and built extensive service capabilities throughout the drug development and commercialization process. Agno has an excellent track record in delivering commercial-scale amplification solutions to clients in North America and Europe.